Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL432981 | 1.00 | ADRB2 (0.39) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL766206 | 1.00 | ADRB2 (0.39) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL8565874 | 1.00 | ADRB2 (0.39) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| Water SCHEMBL27572370 | 0.97 | ADRB2 (0.38) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL1608585 | 0.95 | ADRB2 (0.36) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL1608586 | 0.95 | ADRB2 (0.36) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL1609590 | 0.95 | ADRB2 (0.36) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL10629447 | 0.92 | THRB (0.35) | TSHRCA1CA2THRB | |
| SCHEMBL17644808 | 0.92 | THRB (0.35) | TSHRCA1CA2THRB | |
| SCHEMBL1609030 | 0.92 | THRB (0.35) | TSHRCA1CA2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12473455-B2 | Polymer-coated substrate and medical analysis device | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2025-11-18 | — | — | US | disclosed |
| EP-3898820-B1 | POLYMERIC COMPOSITIONS WITH HIGH DIELECTRIC CONSTANT AND LOW DIELECTRIC LOSS | CELANESE POLYMERS HOLDINGS INC (US) | 2025-05-28 | — | — | EP | disclosed |
| US-12247123-B2 | Polymeric compositions with high dielectric constant and low dielectric loss | CELANESE POLYMERS HOLDING, INC. (US) | 2025-03-11 | — | — | US | disclosed |
| US-12145937-B2 | Process for preparing bicyclic guanidines | WACKER CHEMIE AG (DE) | 2024-11-19 | — | — | US | disclosed |
| EP-4093817-B1 | POLYMER COMPOSITE WITH LOW DIELECTRIC CONSTANT | DUPONT POLYMERS INC (US) | 2024-04-10 | — | — | EP | disclosed |
| US-20230357597-A1 | POLYMER-COATED SUBSTRATE AND MEDICAL ANALYSIS DEVICE | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2023-11-09 | — | — | US | disclosed |
| US-20230340234-A1 | POLYMER COMPOSITE WITH LOW DIELECTRIC CONSTANT | DUPONT POLYMERS INC (US) | 2023-10-26 | — | — | US | disclosed |
| EP-4253337-A1 | POLYMER-COATED SUBSTRATE AND MEDICAL ANALYSIS DEVICE | Sumitomo Rubber Industries, Ltd. (JP) | 2023-10-04 | — | — | EP | disclosed |
| CN-116554651-A | Polymer composite with low dielectric constant | 杜邦聚合物有限公司 | 2023-08-08 | — | — | CN | disclosed |
| CN-113614163-B | Polymer composition with high dielectric constant and low dielectric loss | 杜邦聚合物公司 | 2023-06-16 | — | — | CN | disclosed |
| US-6271293-B1 | Non-staining coating composition | SK KAKEN CO., LTD. (JP) | 2001-08-07 | — | — | US | disclosed |
| EP-1051461-A2 | FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE | ORR, William C. (US) | 2000-11-15 | — | — | EP | disclosed |
| WO-1999066009-A2 | FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE | ORR WILLIAM C (US) | 1999-12-23 | — | — | WO | disclosed |
| EP-0954558-A1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR, William C. (US) | 1999-11-10 | — | — | EP | disclosed |
| WO-1998026028-A1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR WILLIAM C (US) | 1998-06-18 | — | — | WO | disclosed |
| US-4855120-A | Production of silane and useful coproducts | ETHYL CORPORATION (US) | 1989-08-08 | — | — | US | disclosed |
| EP-0007713-B1 | METHOD OF SYNTHESISING IMOGOLITE AND PRODUCT OF THE METHOD | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1982-06-02 | — | — | EP | disclosed |
| US-4241035-A | FROM ALUMINUM ALKOXIDE AND TETRAALKYL AILICATE | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1980-12-23 | — | — | US | disclosed |
| US-4229495-A | ZINC AND ALUMINUM POWDER, TETRAALKYL SILICATE, PRIMER FOR METAL TO BE COATED WITH POLYPHENYLENE SULFIDE | SEIKISUI KAGAKU KOGYO KABUSHIKI LTD. (JP) | 1980-10-21 | — | — | US | disclosed |
| US-4172734-A | ZINC, ALUMINUM, SILICATE | SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1979-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12145937-B2 | Process for preparing bicyclic guanidines | SMOX, CYP4X1, CDY1; CDY1B | ADRB2 326/4885ADRB1 295/4885ADRB3 475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.